跳至主要内容
临床试验/NCT03492970
NCT03492970已完成不适用

Characterization of Behavioral Disorders and 24 H-melatonin Level in Adults With Smith Magenis Syndrome

Hôpital le Vinatier2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年3月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
2
主要终点
24h melatonin levels

研究概览

简要总结

Sleep-Wake and behavioral disorders in Smith Magenis Syndrome (SMS) are strongly linked to an inversion of the nychtemeral secretion of melatonin. This inversion have been described in children with SMS. However its evolution during adulthood remains unknown. The aim of this study is to assess 24hours melatonin levels in 10 adults with SMS in order to optimize medication in adults with SMS

详细描述

SMS is one of the rare syndromes in which the inversion of melatonin secretion is regular, which is an exceptional situation for the study of the influence of genetic factors on the regulation of sleep / wake rhythm. Recently, point mutations of the RAI1 gene (Retinoic Acid Induced 1) have been identified in individuals with the clinical features of SMS with a reversal of the secretion rate of melatonin ,highlighting the role of RAI1 in SMS sleep disorders.

Daytime secretion of melatonin is associated with significant drowsiness and plays a major role in diurnal behavior disorders, especially in younger people. Conversely, the absence of nocturnal melatonin is a causal factor in the shortening and fragmentation of nocturnal sleep .

Basically, little is known about the mechanisms that explain the inversion of the secretion rate of melatonin in SMS.

These aspects, and in particular the nycthemeral reversal of the melatonin cycle, have been described in a population of children and we do not know how these disturbances evolve in adulthood

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with Smith Magenis Syndrome aged 18 years or older
  • subject or guardian having signed the consent

排除标准

  • Pregnant women
  • Minor subject
  • Diagnosis of Smith Magenis syndrome not certain
  • Taking benzodiazepines or related substances
  • Taking betablockers
  • Major behavioral disorders versus indicating participation in this study

研究组 & 干预措施

10 adult patients with SMS

Other

Specify the evolution of the nycthemeral cycle of melatonin secretion in adult subjects carrying an SMS Behavioral characterization of adult subjects with SMS Make recommendations on the management of sleep / sleep rhythm disorders and behavior in adult subjects with SMS

干预措施: Hourly dosing of the nychtemeral secretion of melatonin (Biological)

结局指标

主要结局

24h melatonin levels

时间窗: 24 hours

Plasmatic melatonin level will be assessed every hour during 24h for each subject

次要结局

  • Analysis of actimetry(15 days)

研究者

发起方
Hôpital le Vinatier
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验